Skip to main content

Review

Combining CDSs and equities

Duggan Asset Management is offering exposure to equity and credit markets with its new capital-protected simple growth product. As well as access to an unusual asset class - credit default swaps - participation is linked to the DJ Eurostoxx 50

Five years and six options

Barclays Bank has issued a five-year product that allows investors to choose the level of protection required and achieve a higher participation rate if they opt for a lower level. Each of six versions of the product has an option on the FTSE 100

Commercial property plays

Morgan Stanley surprised many people in July 2008 when it plumped for a commercial property-based product. With lower volatility than was on offer from the FTSE 100, it made for a relatively generous offer of returns that took 65% of the starting level…

Buying in a flat market

Credit Suisse has launched buffered accelerated return equity securities linked to the S&P 500 index, in which participation can be as high as 500%, subject to a 20% maximum return in addition to principal

Dual path to capped returns

Investors in Merrill Lynch's Australian capital-at-risk product have the chance to construct their own product from a choice of two series, each with its own issue price and maximum return based on the performance of the S&P/ASX 200

Capital protection plus bonus

HSBC Global Markets is offering a protected FTSE annual bonus plan with capital protection and a return of up to 6% per annum. The product compares favourably to a kickout, although there the highest possible annual returns are limited

Heineken

Our regular look at groundbreaking and innovative deals in the primary markets takes in the £400 million unrated Heineken deal, and BP's monster $3.25 billion offering

Roche

An in-depth look at the primary market's most innovative transactions. This month: the $16bn deal from Swiss pharma firm Roche, and Westpac's yen issue

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here